Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices 78973 

exemption will be valid for 2 years 

unless rescinded earlier by FMCSA. The 

exemption will be rescinded if: (1) the 

person fails to comply with the terms 

and conditions of the exemption; (2) the 

exemption has resulted in a lower level 

of safety than was maintained before it 

was granted; or (3) continuation of the 

exemption would not be consistent with 

the goals and objectives of 49 U.S.C. 

31136(e) and 31315(b). 

VI. Preemption 

During the period the exemption is in 

effect, no State shall enforce any law or 

regulation that conflicts with this 

exemption with respect to a person 

operating under the exemption. 

VII. Conclusion 

Based upon its evaluation of the 23 

exemption applications, FMCSA renews 

the exemptions of the aforementioned 

drivers from the hearing requirement in 

391.41(b)(11). In accordance with 49 

U.S.C. 31136(e) and 31315(b), each 

exemption will be valid for 2 years 

unless revoked earlier by FMCSA. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2024–21990 Filed 9–25–24; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2012–0294; FMCSA– 

2013–0443; FMCSA–2013–0445; FMCSA– 

2014–0212; FMCSA–2014–0213; FMCSA– 

2015–0321; FMCSA–2018–0051; FMCSA– 

2018–0052; FMCSA–2018–0054; FMCSA– 

2019–0033; FMCSA–2020–0046; FMCSA– 

2022–0044] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of renewal of 

exemptions; request for comments. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for 15 

individuals from the requirement in the 

Federal Motor Carrier Safety 

Regulations (FMCSRs) that interstate 

commercial motor vehicle (CMV) 

drivers have ‘‘no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause loss of consciousness or any 

loss of ability to control a CMV.’’ The 

exemptions enable these individuals 

who have had one or more seizures and 

are taking anti-seizure medication to 

continue to operate CMVs in interstate 

commerce. 

DATES: The exemptions are applicable 

on October 21, 2024. The exemptions 

expire on October 21, 2026. Comments 

must be received on or before October 

28, 2024. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System Docket No. 

FMCSA–2012–0294, Docket No. 

FMCSA–2013–0443, Docket No. 

FMCSA–2013–0445, Docket No. 

FMCSA–2014–0212, Docket No. 

FMCSA–2014–0213, Docket No. 

FMCSA–2015–0321, Docket No. 

FMCSA–2018–0051, Docket No. 

FMCSA–2018–0052, Docket No. 

FMCSA–2018–0054, Docket No. 

FMCSA–2019–0033, Docket No. 

FMCSA–2020–0046, or Docket No. 

FMCSA–2022–0044 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov/, insert the docket 

number (FMCSA–2012–0294, FMCSA– 

2013–0443, FMCSA–2013–0445, 

FMCSA–2014–0212, FMCSA–2014– 

0213, FMCSA–2015–0321, FMCSA– 

2018–0051, FMCSA–2018–0052, 

FMCSA–2018–0054, FMCSA–2019– 

0033, FMCSA–2020–0046, or FMCSA– 

2022–0044) in the keyword box and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, and click on the 

‘‘Comment’’ button. Follow the online 

instructions for submitting comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Washington, DC 20590– 

0001. 

• Hand Delivery: West Building 

Ground Floor, 1200 New Jersey Avenue 

SE, Washington, DC 20590–0001 

between 9 a.m. and 5 p.m. ET Monday 

through Friday, except Federal 

Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, FMCSA, DOT, 1200 

New Jersey Avenue SE, Washington, DC 

20590–0001, (202) 366–4001, 

fmcsamedical@dot.gov. Office hours are 

from 8:30 a.m. to 5 p.m. ET Monday 

through Friday, except Federal holidays. 

If you have questions regarding viewing 

or submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2012–0294, 

Docket No. FMCSA–2013–0443, Docket 

No. FMCSA–2013–0445, Docket No. 

FMCSA–2014–0212, Docket No. 

FMCSA–2014–0213, Docket No. 

FMCSA–2015–0321, Docket No. 

FMCSA–2018–0051, Docket No. 

FMCSA–2018–0052, Docket No. 

FMCSA–2018–0054, Docket No. 

FMCSA–2019–0033, Docket No. 

FMCSA–2020–0046, or Docket No. 

FMCSA–2022–0044), indicate the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. You may submit your 

comments and material online or by fax, 

mail, or hand delivery, but please use 

only one of these means. FMCSA 

recommends that you include your 

name and a mailing address, an email 

address, or a phone number in the body 

of your document so that FMCSA can 

contact you if there are questions 

regarding your submission. 

To submit your comment online, go to 

www.regulations.gov/, insert the docket 

number (FMCSA–2012–0294, FMCSA– 

2013–0443, FMCSA–2013–0445, 

FMCSA–2014–0212, FMCSA–2014– 

0213, FMCSA–2015–0321, FMCSA– 

2018–0051, FMCSA–2018–0052, 

FMCSA–2018–0054, FMCSA–2019– 

0033, FMCSA–2020–0046, or FMCSA– 

2022–0044) in the keyword box and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, click the ‘‘Comment’’ 

button, and type your comment into the 

text box on the following screen. Choose 

whether you are submitting your 

comment as an individual or on behalf 

of a third party and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. FMCSA will consider 

all comments and material received 

during the comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number (FMCSA–2012–0294, FMCSA– 

2013–0443, FMCSA–2013–0445, 

FMCSA–2014–0212, FMCSA–2014– 

0213, FMCSA–2015–0321, FMCSA– 

2018–0051, FMCSA–2018–0052, 

FMCSA–2018–0054, FMCSA–2019– 

0033, FMCSA–2020–0046, or FMCSA– 

2022–0044) in the keyword box and 


khammond on DSKJM1Z7X2PROD with NOTICES
78974 Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, and click ‘‘Browse 

Comments.’’ If you do not have access 

to the internet, you may view the docket 

online by visiting Dockets Operations 

on the ground floor of the DOT West 

Building, 1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m. ET Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 

please call (202) 366–9317 or (202) 366– 

9826 before visiting Dockets Operations. 

C. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

request. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov. As described in 

the system of records notice DOT/ALL 

14 (Federal Docket Management 

System), which can be reviewed at 

https://www.transportation.gov/ 

individuals/privacy/privacy-act-systemrecords-notices, the comments are 

searchable by the name of the submitter. 

II. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 

greater than, the level that would be 

achieved absent such exemption. The 

statutes also allow the Agency to renew 

exemptions at the end of the 5-year 

period. However, FMCSA grants 

medical exemptions from the FMCSRs 

for a 2-year period to align with the 

maximum duration of a driver’s medical 

certification. 

The physical qualification standard 

for drivers regarding epilepsy found in 

49 CFR 391.41(b)(8) states that a person 

is physically qualified to drive a CMV 

if that person has no established 

medical history or clinical diagnosis of 

epilepsy or any other condition which 

is likely to cause the loss of 

consciousness or any loss of ability to 

control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist Medical Examiners in 

determining whether drivers with 

certain medical conditions are qualified 

to operate a CMV in interstate 

commerce. 

The 15 individuals listed in this 

notice have requested renewal of their 

exemptions from the epilepsy and 

seizure disorders prohibition in 

§ 391.41(b)(8), in accordance with 

FMCSA procedures. Accordingly, 

FMCSA has evaluated these 

applications for renewal on their merits 

and decided to extend each exemption 

for a renewable 2-year period. 

III. Request for Comments 

Interested parties or organizations 

possessing information that would 

otherwise show that any, or all, of these 

drivers are not currently achieving the 

statutory level of safety should 

immediately notify FMCSA. The 

Agency will evaluate any adverse 

evidence submitted and, if safety is 

being compromised or if continuation of 

the exemption would not be consistent 

with the goals and objectives of 49 

U.S.C. 31136(e) and 31315(b), FMCSA 

will take immediate steps to revoke the 

exemption of a driver. 

IV. Basis for Renewing Exemptions 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), each of the 15 applicants 

has satisfied the renewal conditions for 

obtaining an exemption from the 

epilepsy and seizure disorders 

prohibition. The 15 drivers in this 

notice remain in good standing with the 

Agency, have maintained their medical 

monitoring and have not exhibited any 

medical issues that would compromise 

their ability to safely operate a CMV 

during the previous 2-year exemption 

period. In addition, for commercial 

driver’s license (CDL) holders, the 

Commercial Driver’s License 

Information System and the Motor 

Carrier Management Information System 

are searched for crash and violation 

data. For non-CDL holders, the Agency 

reviews the driving records from the 

State Driver’s Licensing Agency. These 

factors provide an adequate basis for 

predicting each driver’s ability to 

continue to safely operate a CMV in 

interstate commerce. Therefore, FMCSA 

concludes that extending the exemption 

for each renewal applicant for a period 

of 2 years is likely to achieve a level of 

safety equal to that existing without the 

exemption. 

As of October 21, 2024, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following 15 individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the 

epilepsy and seizure disorders 

prohibition in the FMCSRs for interstate 

CMV drivers: 

Lee Anderson (MA) 

Jay Asack (MA) 

Peter Bender (MN) 

Ronald Blount (GA) 

Eric Hilmer (WI) 

Lucas Meeker (OH) 

Roland Mezger (PA) 

Roger Parker (NC) 

Nicholas Ramirez (CA) 

Michael Ranalli (PA) 

Bryan Sheehan (FL) 

Matthew Staley (CO) 

Joshua Thomas (MN) 

Robert Thomas, Jr. (NC) 

Peter Thompson (FL) 

The drivers were included in docket 

number FMCSA–2012–0294, FMCSA– 

2013–0443, FMCSA–2013–0445, 

FMCSA–2014–0212, FMCSA–2014– 

0213, FMCSA–2015–0321, FMCSA– 

2018–0051, FMCSA–2018–0052, 

FMCSA–2018–0054, FMCSA–2019– 

0033, FMCSA–2020–0046, or FMCSA– 

2022–0044. Their exemptions are 

applicable as of October 21, 2024 and 

will expire on October 21, 2026. 

V. Conditions and Requirements 

The exemptions are extended subject 

to the following conditions: (1) each 

driver must remain seizure-free and 

maintain a stable treatment during the 

2-year exemption period; (2) each driver 

must submit annual reports from their 

treating physicians attesting to the 

stability of treatment and that the driver 

has remained seizure-free; (3) each 

driver must undergo an annual medical 

examination by a certified ME, as 

defined by § 390.5; and (4) each driver 

must provide a copy of the annual 

medical certification to the employer for 

retention in the driver’s qualification 

file, or keep a copy of his/her driver’s 

qualification file if he/she is selfemployed. The driver must also have a 

copy of the exemption when driving, for 

presentation to a duly authorized 

Federal, State, or local enforcement 

official. The exemption will be 

rescinded if: (1) the person fails to 

comply with the terms and conditions 

of the exemption; (2) the exemption has 

resulted in a lower level of safety than 

was maintained before it was granted; or 

(3) continuation of the exemption would 

not be consistent with the goals and 

objectives of 49 U.S.C. 31136(e) and 

31315(b). 

VI. Preemption 

During the period the exemption is in 

effect, no State shall enforce any law or 

regulation that conflicts with this 

exemption with respect to a person 

operating under the exemption. 

VII. Conclusion 

Based on its evaluation of the 15 

exemption applications, FMCSA renews 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices 78975 

the exemptions of the aforementioned 

drivers from the epilepsy and seizure 

disorders prohibition in § 391.41(b)(8). 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), each exemption will be 

valid for 2 years unless revoked earlier 

by FMCSA. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2024–21999 Filed 9–25–24; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Office of the Secretary 

[Docket No. DOT–OST–2024–0098] 

Transforming Transportation Advisory 

Committee; Public Meeting 

AGENCY: Office of the Secretary (OST), 

Department of Transportation (DOT). 

ACTION: Notice of public meeting. 

SUMMARY: The Office of the Secretary of 

Transportation (OST) announces a 

public meeting of the Transforming 

Transportation Advisory Committee 

(TTAC) on Thursday, October 17, 2024. 

This notice announces the date, time, 

and location of the meeting, which will 

be virtually open to the public. The 

purpose of the TTAC is to provide 

information, advice, and 

recommendations to the Secretary on 

matters relating to transportation 

innovations. 

DATES: This meeting will be held on 

Thursday, October 17, 2024 from 11:00 

a.m. to 3:30 p.m. Eastern Time (ET). A 

link allowing for live viewing of the 

meeting will be posted to https://

www.transportation.gov/ttac ahead of 

the meeting start time. 

ADDRESSES: The TTAC members will be 

meeting virtually via Zoom. The public 

may attend the meeting virtually, with 

information available on the USDOT 

TTAC website (https://

www.transportation.gov/ttac) at least 

one week in advance of the meeting 

date. 

FOR FURTHER INFORMATION CONTACT: 

TTAC Designated Federal Officer, c/o 

Ben Levine, Deputy Assistant Secretary 

for Research and Technology, Office of 

the Secretary, ttac@dot.gov, (202) 941– 

6180. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The U.S. Secretary of Transportation 

(Secretary) established TTAC as a 

Federal Advisory Committee in 

accordance with the Federal Advisory 

Committee Act (Pub. L. 92–463, 5 U.S.C. 

ch. 10) to provide information, advice, 

and recommendations to the Secretary 

on matters relating to transportation 

innovations. TTAC is tasked with 

advice and recommendations to the 

Secretary about needs, objectives, plans, 

and approaches for transportation 

innovations. 

Description of Duties 

TTAC will undertake only tasks 

assigned to it by the Secretary of 

Transportation or designee and provide 

direct, first-hand information, advice, 

and recommendations by meeting and 

exchanging ideas on the tasks assigned. 

In addition, TTAC will respond to adhoc informational requests from OST. 

II. Agenda 

At the meeting, the agenda will cover 

the following topics: 

1. Call to Order, Official Statement of 

the Designated Federal Officer, 

Meeting Logistics 

2. Opening Remarks 

3. Subcommittee Updates 

4. Recap of Meeting Progress and 

Review of Next Steps 

III. Public Participation 

The meeting will be open to the 

public via livestream. Members of the 

public who wish to observe the virtual 

meeting can access the livestream 

accessible on the following website: 

https://www.transportation.gov/ttac. 

We are committed to providing equal 

access to this meeting for all 

participants. Sign language 

interpretation and live-captioning will 

be available during the livestream. If 

you need alternative formats or services 

because of a disability, such as 

interpretation or other ancillary aids, or 

if you require translation into a language 

other than English, please contact the 

person listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice no later than Thursday, October 

10, 2024. 

Members of the public may also 

submit written materials, questions, and 

comments to the Committee in advance 

to the individual listed in the FOR

FURTHER INFORMATION CONTACT section of 

this notice no later than Thursday, 

October 10, 2024. 

All advance submissions will be 

reviewed by the Designated Federal 

Officer. If approved, advance 

submissions shall be circulated to the 

TTAC members for review prior to the 

meeting. All advance submissions will 

become part of the official record of the 

meeting. 

Authority: The Committee is a 

discretionary Committee under the 

authority of the U.S. Department of 

Transportation (DOT), established in 

accordance with the provisions of the 

Federal Advisory Committee Act 

(FACA), as amended, 5 U.S.C. ch. 2. 

Issued in Washington, DC, on September 

20, 2024. 

Benjamin Ross Levine, 

Deputy Assistant Secretary for Research and 

Technology. 

[FR Doc. 2024–21980 Filed 9–25–24; 8:45 am] 

BILLING CODE 4910–9X–P 

DEPARTMENT OF THE TREASURY 

Office of Foreign Assets Control 

Notice of OFAC Sanctions Actions 

AGENCY: Office of Foreign Assets 

Control, Treasury. 

ACTION: Notice. 

SUMMARY: The U.S. Department of the 

Treasury’s Office of Foreign Assets 

Control (OFAC) is publishing the names 

of one or more persons that have been 

placed on OFAC’s Specially Designated 

Nationals and Blocked Persons List 

(SDN List), based on OFAC’s 

determination that one or more 

applicable legal criteria were satisfied. 

All property and interests in property 

subject to U.S. jurisdiction of these 

persons are blocked, and U.S. persons 

are generally prohibited from engaging 

in transactions with them. Additionally, 

OFAC is publishing updates to the 

identifying information of two persons 

currently included on the SDN List. 

DATES: See SUPPLEMENTARY INFORMATION

section for applicable date. 

FOR FURTHER INFORMATION CONTACT: 

OFAC: Associate Director for Global 

Targeting, tel.: 202–622–2420; Assistant 

Director for Licensing, tel.: 202–622– 

2480; Assistant Director for Regulatory 

Affairs, tel.: 202–622–4855; or Assistant 

Director for Sanctions Compliance & 

Evaluation, tel.: 202–622–2490. 

SUPPLEMENTARY INFORMATION: 

Electronic Availability 

The SDN List and additional 

information concerning OFAC sanctions 

programs are available on OFAC’s 

website (https://www.treasury.gov/ofac). 

Notice of OFAC Actions 

A. On September 19, 2024, OFAC 

determined that the property and 

interests in property subject to U.S. 

jurisdiction of the following persons 

and entities are blocked under the 

relevant sanctions authorities listed 

below. 

BILLING CODE 4810–AL–P 


khammond on DSKJM1Z7X2PROD with NOTICES